nitroglycerin has been researched along with naproxen in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (45.45) | 29.6817 |
| 2010's | 4 (36.36) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Condorelli, M; Cuocolo, A; De Simone, A; Patrono, C; Ricciardelli, B; Trimarco, B; Volpe, M | 1 |
| Condorelli, M; Cuocolo, A; De Simone, A; Ricciardelli, B; Trimarco, B; Van Dorne, D; Volpe, M | 1 |
| Cirino, G; Lovren, F; McKnight, W; Muscará, MN; Triggle, CR; Wallace, JL | 1 |
| Cökmez, A; Deniz, S; Genç, H; Gür, S; Tarcan, E | 1 |
| Berndt, G; Grosser, N; Hoogstraate, J; Schröder, H | 1 |
| Adding, LC; Agvald, P; Andersson, LI; Gustafsson, LE; Hoogstraate, J; Jonzon, B | 1 |
| Akar, S; Akkoc, N; Can, G; Ceylan, I; Sari, I; Secil, M; Solmaz, D | 1 |
1 review(s) available for nitroglycerin and naproxen
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for nitroglycerin and naproxen
| Article | Year |
|---|---|
Effect of transdermal glyceryl trinitrate and anti-inflammatory gel in infusion phlebitis.
Topics: Administration, Cutaneous; Adult; Anti-Inflammatory Agents, Non-Steroidal; Female; Gels; Humans; Infusions, Intravenous; Male; Naproxen; Nitroglycerin; Phlebitis; Prospective Studies | 2003 |
The effect of non-steroidal anti-inflammatory drugs on the endothelial function of patients with osteoarthritis in short term.
Topics: Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Brachial Artery; Cyclooxygenase Inhibitors; Diclofenac; Endothelium, Vascular; Female; Humans; Male; Middle Aged; Naproxen; Nitroglycerin; Osteoarthritis; Prospective Studies; Treatment Outcome; Vasodilation | 2012 |
8 other study(ies) available for nitroglycerin and naproxen
| Article | Year |
|---|---|
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Indomethacin blunts the late phase of nitroglycerin-induced coronary vasodilatation in dogs.
Topics: Animals; Blood Pressure; Coronary Vessels; Cyclooxygenase Inhibitors; Dogs; Female; Heart Rate; Indomethacin; Injections, Intra-Arterial; Male; Naproxen; Nitroglycerin; Thromboxane B2; Vasodilation | 1985 |
Late phase of nitroglycerin-induced coronary vasodilatation blunted by inhibition of prostaglandin synthesis.
Topics: Animals; Coronary Circulation; Dogs; Dose-Response Relationship, Drug; Female; Indomethacin; Male; Naproxen; Nitroglycerin; Prostaglandin Antagonists; Prostaglandins; Vasodilation | 1985 |
Antihypertensive properties of a nitric oxide-releasing naproxen derivative in two-kidney, one-clip rats.
Topics: Animals; Aorta, Thoracic; Blood Pressure; Endothelin-1; Hypertension, Renovascular; In Vitro Techniques; Isometric Contraction; Male; Muscle, Smooth, Vascular; Naproxen; Nitrates; Nitric Oxide Donors; Nitrites; Nitroglycerin; Nitroprusside; Phenylephrine; Rats; Rats, Wistar; Renal Artery; Thromboxane B2 | 2000 |
A common pathway of nitric oxide release from AZD3582 and glyceryl trinitrate.
Topics: Animals; Cyclic GMP; Cyclooxygenase Inhibitors; LLC-PK1 Cells; Molsidomine; Naphthalenes; Naproxen; Nitric Oxide; Nitric Oxide Donors; Nitroglycerin; Swine | 2004 |
Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivo.
Topics: Acid-Base Equilibrium; Air; Animals; Blood Pressure; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Enzyme Inhibitors; Gases; Heart Rate; Hemoglobins; In Vitro Techniques; Male; Naphthalenes; Naproxen; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitroglycerin; Prostaglandin-Endoperoxide Synthases; Rabbits; Vasodilator Agents | 2005 |